ClearPoint Neuro (CLPT) is scheduled to report Q2 earnings on August 11, 2026. Analysts estimate EPS of $-0.28 and quarterly revenue of $12.79M.
In the most recent quarter (Q1), ClearPoint Neuro reported EPS of $-0.32, missing estimates of $-0.27 by 0.19%. Revenue came in at $12.13M, exceeding the estimate of $12.02M by 0.01%.
ClearPoint Neuro has missed EPS estimates in 7 consecutive quarters.
Over the last 4 quarters, ClearPoint Neuro has averaged an EPS surprise of 0.10% and a revenue surprise of 0.04%.
Analyze the earnings history of ClearPoint Neuro using advanced sorting and filters.
The chart below shows ClearPoint Neuro's reported EPS compared to analyst estimates over recent quarters.
The chart below shows ClearPoint Neuro's reported revenue compared to analyst estimates over recent quarters.
ClearPoint Neuro (CLPT) is scheduled to report earnings on August 11, 2026. The last reported earnings were for reported on May 13, 2026 for Q1.
The Actual EPS was $-0.32, which missed the estimate of $-0.27.
The Actual Revenue was $12.13M, which beat the estimate of $12.02M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-05-13 | $-0.32 | $-0.27 | -18.5 % |
| Q4 | 2026-03-17 | $-0.23 | $-0.21 | -9.52 % |
| Q3 | 2025-11-06 | $-0.21 | $-0.20 | -5.00 % |
| Q2 | 2025-08-12 | $-0.21 | $-0.20 | -5.00 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-05-13 | $12.13M | $12.02M | 0.87 % |
| Q4 | 2026-03-17 | $10.40M | $9.91M | 4.94 % |
| Q3 | 2025-11-06 | $8.86M | $9.72M | -8.84 % |
| Q2 | 2025-08-12 | $9.22M | $9.32M | -1.13 % |